Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Aug
22
2019
NIOSH Publishes One-Pager on Nanotechnology Research Center’s Accomplishments and Future Activities Bergeson & Campbell, P.C.
Aug
22
2019
EPA Seeks Public Comment on First-Ever Hemp Pesticide Applications Beveridge & Diamond PC
Aug
22
2019
In A Reckless Re-Price, Results Are Not Realized K&L Gates
Aug
22
2019
New York State Decriminalizes Possession of Marijuana Epstein Becker & Green, P.C.
Aug
22
2019
FDA Issues Guidance on Conversion Factors for Various Nutrients Keller and Heckman LLP
Aug
22
2019
Sometimes You Feel Like a Nut Pierce Atwood LLP
Aug
22
2019
Are Efforts to Speed Up Antitrust Merger Reviews Working? Epstein Becker & Green, P.C.
Aug
21
2019
NCUA Issues New Guidance to Credit Unions Which Permits Hemp Banking Dinsmore & Shohl LLP
Aug
21
2019
Update: Recent Momentum in Efforts to Provide Cannabis Businesses Access to Financial Services Ballard Spahr LLP
Aug
21
2019
Third Circuit Upholds Decision Blocking Trump Administration’s Birth Control Rules McDermott Will & Emery
Aug
21
2019
ANDA Applicant Dismissed for Lack of Venue Under § 1400(b) as District of New Jersey Departs from its own and the District of Delaware’s Prior Rulings Mintz
Aug
21
2019
FDA Sued for Failure to Establish FSMA Accredited Labs Program by Statutory Deadline Keller and Heckman LLP
Aug
20
2019
Blockchain Will Likely Have to Meaningful Impact on “Big Food” Litigation Bilzin Sumberg
Aug
20
2019
SEC Signals New Phase of Regulation FD Enforcement Ballard Spahr LLP
Aug
20
2019
Opioid MDL Judge Considers Request to Certify Unprecedented Nationwide Class Of Government Entities To Negotiate Settlement Foley & Lardner LLP
Aug
20
2019
Japan Notifies WTO of its New Positive List for Plastic Food-Contact Materials Keller and Heckman LLP
Aug
20
2019
CFTC v. Kraft Dispute Continues with CFTC on Defensive Bracewell LLP
Aug
20
2019
TTB Label Approval System Survives First Amendment Challenge from DC Brewery McDermott Will & Emery
Aug
20
2019
USDA No Longer Requires Pet Food to be Manufactured During Hours of Inspectional Supervision Keller and Heckman LLP
Aug
20
2019
Doctrine Of Equivalents Not Barred By Claim Amendments Foley & Lardner LLP
Aug
19
2019
TTB Publishes New Nonbeverage Product Formula Form McDermott Will & Emery
Aug
19
2019
Where's the Beef? Motion to Dismiss Granted Based on Emergency Exception & Extrinsic Evidence Womble Bond Dickinson (US) LLP
Aug
19
2019
Vapor Industry Trade Groups Seek to Intervene and Appeal Decision on PMTA Deadline; VTA Files Lawsuit Against FDA Keller and Heckman LLP
Aug
19
2019
EPA Announces FIFRA SAP Public Meeting to Consider Approaches for Incorporating Surface Water Monitoring Data in Pesticide Risk Assessments and Requests Nominations of Ad hoc Expert Reviewers Bergeson & Campbell, P.C.
Aug
19
2019
Spate of Recent False Advertising Class Actions Take On Animal Treatment Label Claims Sheppard, Mullin, Richter & Hampton LLP
Aug
19
2019
Bridging the Week by Gary DeWaal: August 12 - 16, and August 19, 2019 (Manipulation Settlement; CFTC Gag Agreement; Digital Securities Offering) Katten
Aug
19
2019
Federal Circuit Cautions Against Rigid Approach to Prosecution History Estoppel in Fourth Appeal from ALIMTA® Litigations Mintz
Aug
18
2019
EPA Begins Public Comment Period for Manufacturer Requests for Risk Evaluations of DIDP and DINP Bergeson & Campbell, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins